| Stem Cell Transplant |
27.9% |
| Cord Blood Transplant Therapy |
22.7% |
| Prophylaxis Against Graft Versus Host Disease |
17.5% |
| Bone Marrow Transplant |
13.1% |
| Graft Versus Host Disease |
3.6% |
| Aplastic Anaemia |
2.7% |
| Prophylaxis |
2.2% |
| Allogenic Bone Marrow Transplantation Therapy |
2.1% |
| Bone Marrow Conditioning Regimen |
1.2% |
| Premedication |
1.0% |
| Acute Lymphocytic Leukaemia |
1.0% |
| Hodgkin's Disease |
1.0% |
| Unrelated Donor Bone Marrow Transplantation Therapy |
0.8% |
| Lymphoma |
0.7% |
| Desmoplastic Small Round Cell Tumour |
0.6% |
| Renal Transplant |
0.6% |
| Hiv Infection |
0.4% |
| Acute Graft Versus Host Disease |
0.3% |
| Acute Graft Versus Host Disease In Skin |
0.3% |
| Chronic Graft Versus Host Disease |
0.3% |